Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Qingdao: Insulin Pump Follow-Up Program
Clinical trial update for an insulin pump follow-up program in Qingdao with terminated status; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: The VIGORous Physical Activity for Glycaemic Control in Type 1 Diabetes (VIGOR) Trial [NA]
A terminated clinical trial assessing physical activity for glycemic control in Type 1 Diabetes; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Microalbuminuria and Allopurinol in Type 1 Diabetes [Phase 4]
A Phase 4 clinical trial update evaluating the effect of allopurinol on microalbuminuria in individuals with Type 1 diabetes and diabetic ne…
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Use of Continuous Glucose Sensors by Adolescents With Inadequate Diabetic Control [NA]
Clinical trial update on using continuous glucose sensors by adolescents with poorly controlled type 1 diabetes; results posted.
-
FDA approval · 2018-09-05FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA supplemental application approval for BASAGLAR KWIKPEN (insulin glargine) filed by Eli Lilly and Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes [Phase 3]
Phase 3 trial evaluating safety and efficacy of inhaled insulin in individuals with Type 1 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2018-09-05Clinical Trial Update: Safety and Feasibility Evaluation of the APS APP [Phase 2, Phase 3]
Safety and feasibility evaluation of the APS APP in Phase 2/Phase 3 for Type 1 Diabetes Mellitus has completed.
-
FDA approval · 2018-09-04FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for FIASP (insulin aspart injection) from Novo Nordisk, authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance [NA]
ACompleted clinical trial evaluating the impact of changing glucose targets on the performance of a bionic pancreas system.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting [Phase 2]
Phase 2 trial update comparing liraglutide to insulin mono-therapy in a closed-loop setting for Type 1 Diabetes; study completed with result…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: The Effects of Empagliflozin on Arterial Wall Characteristics [Phase 4]
Phase 4 trial investigating the effects of empagliflozin on arterial wall characteristics in individuals with vascular stiffness and diabete…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes [Phase 1, Phase 2]
Adaptive study evaluating how different IL-2 dose frequencies affect regulatory T cells in individuals with Type 1 Diabetes; the trial has c…
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus [Phase 4]
A Phase 4 trial comparing morning injections of Toujeo versus Lantus in adults with Type 1 Diabetes Mellitus has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Threshold Suspend in Pediatrics at Home [NA]
Completed pediatric at-home threshold suspend trial for Type 1 Diabetes; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes [Phase 3]
Phase 3 trial comparing faster-acting insulin aspart with NovoRapid in adults with type 1 diabetes, evaluating efficacy and safety when used…
-
FDA approval · 2018-08-09FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for TRESIBA insulin degludec (Novo Nordisk).
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes [NA]
A completed trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with Type 1 diabetes; …
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial evaluating imatinib treatment in recent-onset type 1 diabetes mellitus has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Comparison of 2 NovoFine® Needles on the Reflux of Insulin [Phase 3]
Phase 3 trial comparing two NovoFine needles in insulin delivery; completed study.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop [Phase 1]
A Phase 1 randomized trial comparing sitagliptin to placebo in a closed-loop system for type 1 diabetes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating mini-dose glucagon to prevent exercise-induced hypoglycemia in adults with Type 1 diabetes; completed with results …
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age [NA]
This is a completed clinical trial update on closed-loop insulin delivery in young children under 7 with Type 1 Diabetes Mellitus; results w…
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes [Phase 1]
A Phase 1 safety trial of PF-06342674 in adults with type 1 diabetes has completed and results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA) [Phase 1, Phase 2]
Phase 1/2 study evaluating Sitagliptin for preserving beta cell function in adults with adult-onset latent autoimmune diabetes (LADA); the t…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control [Phase 2]
A Phase 2 trial compared hepatic-directed vesicle insulin lispro (HDV-insulin lispro) to standard insulin lispro in Type 1 diabetes to impro…